• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL1、CXCL2、CXCL3和CXCL8作为宫颈癌潜在预后标志物的价值:人乳头瘤病毒16型和18型E6/E7在趋化因子调控中的证据

The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation.

作者信息

Fernandez-Avila Leonardo, Castro-Amaya Aribert Maryosly, Molina-Pineda Andrea, Hernández-Gutiérrez Rodolfo, Jave-Suarez Luis Felipe, Aguilar-Lemarroy Adriana

机构信息

Programa de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

División de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.

出版信息

Biomedicines. 2023 Sep 28;11(10):2655. doi: 10.3390/biomedicines11102655.

DOI:10.3390/biomedicines11102655
PMID:37893029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10604789/
Abstract

Cervical cancer (CC) is a serious global health issue, and it is well-known that HPV infection is the main etiological factor that triggers carcinogenesis. In cancer, chemokine ligands and receptors are involved in tumor cell growth, metastasis, leukocyte infiltration, and angiogenesis; however, information on the role played by E6/E7 of HPV16/18 in the modulation of chemokines is very limited. Therefore, this study aimed to determine whether chemokines are differentially expressed in CC-derived cell lines; if E6/E7 oncoproteins from HPV16 and 18 are capable of mediating chemokine expression, what is the expression profile of chemokines in tissues derived from CC and what is their impact on the overall survival of patients with this pathology? For this purpose, RNA sequencing and real-time PCR were performed on SiHa, HeLa, and C33A tumorigenic cell lines, on the non-tumorigenic HaCaT cells, and the HPV-transduced HaCaT cell models. Furthermore, chemokine expression and survival analysis were executed on 304 CC and 22 normal tissue samples from The Cancer Genome Atlas (TCGA) repository. The results demonstrate that , , , and are regulated by of HPV16 and 18, are overexpressed in CC biopsies, and that their higher expression is related to a worse prognostic survival.

摘要

宫颈癌(CC)是一个严重的全球健康问题,众所周知,人乳头瘤病毒(HPV)感染是引发癌变的主要病因。在癌症中,趋化因子配体和受体参与肿瘤细胞生长、转移、白细胞浸润及血管生成;然而,关于HPV16/18的E6/E7在趋化因子调节中所起作用的信息非常有限。因此,本研究旨在确定趋化因子在CC衍生细胞系中是否差异表达;如果来自HPV16和18的E6/E7癌蛋白能够介导趋化因子表达,那么趋化因子在CC衍生组织中的表达谱是怎样的,以及它们对这种病理状况患者的总生存期有何影响?为此,对SiHa、HeLa和C33A致瘤细胞系、非致瘤性HaCaT细胞以及HPV转导的HaCaT细胞模型进行了RNA测序和实时PCR。此外,对来自癌症基因组图谱(TCGA)数据库的304份CC组织样本和22份正常组织样本进行了趋化因子表达和生存分析。结果表明, 、 、 和 受HPV16和18的 调控,在CC活检组织中过表达,且其较高表达与较差的预后生存相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/af2268aeca26/biomedicines-11-02655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/5df825e1b254/biomedicines-11-02655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/0c536983088a/biomedicines-11-02655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/c5aee849815c/biomedicines-11-02655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/af2268aeca26/biomedicines-11-02655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/5df825e1b254/biomedicines-11-02655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/0c536983088a/biomedicines-11-02655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/c5aee849815c/biomedicines-11-02655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517d/10604789/af2268aeca26/biomedicines-11-02655-g004.jpg

相似文献

1
The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation.CXCL1、CXCL2、CXCL3和CXCL8作为宫颈癌潜在预后标志物的价值:人乳头瘤病毒16型和18型E6/E7在趋化因子调控中的证据
Biomedicines. 2023 Sep 28;11(10):2655. doi: 10.3390/biomedicines11102655.
2
Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.丝氨酸/苏氨酸激酶31(STK31)可能是HPV16癌基因E7的一个新型细胞靶基因,有潜力作为宫颈癌中DNA低甲基化生物标志物。
Virol J. 2016 Apr 5;13:60. doi: 10.1186/s12985-016-0515-5.
3
E6/E7 and E6 From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes.E6/E7 和 HPV16、HPV18 的 E6 上调角质形成细胞中的 IL-6 表达,与 p53 无关。
Front Immunol. 2019 Jul 23;10:1676. doi: 10.3389/fimmu.2019.01676. eCollection 2019.
4
E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.高危型人乳头瘤病毒16(HPV-16)的E6/E7癌蛋白上调基质金属蛋白酶-1(MT1-MMP)、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的表达,并促进宫颈癌细胞的迁移。
Int J Clin Exp Pathol. 2015 May 1;8(5):4981-9. eCollection 2015.
5
Interaction between 17β-estradiol, prolactin and human papillomavirus induce E6/E7 transcript and modulate the expression and localization of hormonal receptors.17β-雌二醇、催乳素与人乳头瘤病毒之间的相互作用诱导E6/E7转录物,并调节激素受体的表达和定位。
Cancer Cell Int. 2019 Sep 2;19:227. doi: 10.1186/s12935-019-0935-6. eCollection 2019.
6
HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.HPV E7 通过 TAL1/lnc-EBIC/KLHDC7B 轴影响宫颈癌细胞的功能。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8002. Epub 2021 Mar 24.
7
Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.环氧化酶-2转录受人类乳头瘤病毒16型E6和E7癌蛋白调控:共抑制因子/共激活因子交换的证据
Cancer Res. 2007 Apr 15;67(8):3976-85. doi: 10.1158/0008-5472.CAN-06-4273.
8
HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.人乳头瘤病毒16型癌基因E6或/和E7可能影响宫颈癌细胞系HT-3中RASSFIA基因启动子区域的甲基化状态。
Oncol Rep. 2017 Apr;37(4):2324-2334. doi: 10.3892/or.2017.5465. Epub 2017 Feb 17.
9
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.通过 CRISPR/Cas13a 系统切割人乳头瘤病毒 E6/E7 mRNA 抑制人宫颈癌细胞的体外和体内生长。
Antiviral Res. 2020 Jun;178:104794. doi: 10.1016/j.antiviral.2020.104794. Epub 2020 Apr 14.
10
Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.人乳头瘤病毒 E6/E7 和长非编码 RNA TMPOP2 相互上调宫颈癌细胞的基因表达。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01808-18. Print 2019 Apr 15.

引用本文的文献

1
Chemokines: humble yet mighty players in the tumour microenvironment.趋化因子:肿瘤微环境中虽不起眼却强大的参与者。
Front Immunol. 2025 Aug 7;16:1601756. doi: 10.3389/fimmu.2025.1601756. eCollection 2025.
2
Construction and validation of a chemokine-related gene signature associated with prognosis, clinical significance, and immune microenvironment characteristics in cervical cancer.与宫颈癌预后、临床意义及免疫微环境特征相关的趋化因子相关基因特征的构建与验证
Discov Oncol. 2025 Jun 15;16(1):1114. doi: 10.1007/s12672-025-02973-7.
3
Development and Validation of an Anoikis-Related Gene Signature for Prognostic Prediction in Cervical Cancer.

本文引用的文献

1
circRNF13, a novel N-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.环状RNA RNF13是一种新型的N-甲基腺苷修饰的环状RNA,它通过提高CXCL1信使核糖核酸的稳定性来增强宫颈癌的放射抗性。
Cell Death Discov. 2023 Jul 20;9(1):253. doi: 10.1038/s41420-023-01557-0.
2
CXCL1 promoted the migration and invasion abilities of oral cancer cells and might serve as a promising marker of prognosis in tongue cancer.CXCL1 促进口腔癌细胞的迁移和侵袭能力,可能成为舌癌预后有前途的标志物。
J Oral Pathol Med. 2023 Aug;52(7):583-592. doi: 10.1111/jop.13418. Epub 2023 Mar 19.
3
用于宫颈癌预后预测的失巢凋亡相关基因特征的开发与验证
Int J Gen Med. 2025 Jun 4;18:2861-2879. doi: 10.2147/IJGM.S508059. eCollection 2025.
4
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk.白细胞介素-8和白细胞介素-16的基因变异及其与宫颈癌风险的关联。
Life (Basel). 2025 Jan 21;15(2):135. doi: 10.3390/life15020135.
5
Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer.单细胞转录组学揭示了早发性与晚发性宫颈癌中多方面的免疫异质性。
World J Surg Oncol. 2025 Jan 14;23(1):12. doi: 10.1186/s12957-025-03654-z.
6
Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy.基于风险调整控制图鉴定和验证吉西他滨联合或不联合厄洛替尼治疗胰腺癌的预测生物标志物。
Front Genet. 2024 Dec 17;15:1497254. doi: 10.3389/fgene.2024.1497254. eCollection 2024.
7
Variable Expression of Oncogene-Induced Senescence/SASP Surrogates in HPV-Associated Precancerous Cervical Tissue.人乳头瘤病毒相关的宫颈癌前组织中癌基因诱导的衰老/衰老相关分泌表型替代物的可变表达
Curr Issues Mol Biol. 2024 Dec 2;46(12):13696-13712. doi: 10.3390/cimb46120818.
8
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis.新兴范式:揭示氧化应激在人乳头瘤病毒诱导的致癌作用中的角色
Infect Agent Cancer. 2024 Jul 2;19(1):30. doi: 10.1186/s13027-024-00581-8.
9
A Retrospective Analysis from Western Romania Comparing the Treatment and Survivability of p16-Positive versus p16-Negative Oropharyngeal Cancer.罗马尼亚西部的一项回顾性分析:比较p16阳性与p16阴性口咽癌的治疗与生存情况
Cancers (Basel). 2024 Feb 26;16(5):945. doi: 10.3390/cancers16050945.
10
Detection of Sialic Acid to Differentiate Cervical Cancer Cell Lines Using a Lectin Biosensor.利用凝集素生物传感器检测唾液酸以区分宫颈癌细胞系。
Biosensors (Basel). 2024 Jan 10;14(1):34. doi: 10.3390/bios14010034.
Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing.
基于人乳头瘤病毒E6剪接构建宫颈癌免疫相关竞争性内源RNA网络
Front Oncol. 2022 Dec 14;12:979884. doi: 10.3389/fonc.2022.979884. eCollection 2022.
4
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
5
EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway.EphA2通过CXCL11/PD-L1途径促进宫颈癌的发展。
J Oncol. 2022 Nov 28;2022:4886907. doi: 10.1155/2022/4886907. eCollection 2022.
6
Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma.趋化因子 CCL14 影响甲状腺癌的临床结局,并与免疫浸润相关。
Histol Histopathol. 2023 Jun;38(6):695-707. doi: 10.14670/HH-18-548. Epub 2022 Nov 21.
7
Role of chemokines in HPV-induced cancers.趋化因子在 HPV 诱导癌症中的作用。
Semin Cancer Biol. 2022 Dec;87:170-183. doi: 10.1016/j.semcancer.2022.11.010. Epub 2022 Nov 17.
8
Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells.人乳头瘤病毒E6和E7蛋白调控的HaCaT细胞中mRNA的表达谱分析及基因功能网络分析
Front Microbiol. 2022 Sep 14;13:979087. doi: 10.3389/fmicb.2022.979087. eCollection 2022.
9
O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer.O-糖基化酶 GALNT2 预测宫颈癌预后不良。
Pathol Oncol Res. 2022 Aug 30;28:1610554. doi: 10.3389/pore.2022.1610554. eCollection 2022.
10
Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.人乳头瘤病毒 16 型 E6 和 E7 癌蛋白改变与 DNA 损伤反应、免疫信号和表皮分化相关的蛋白质的丰度。
Viruses. 2022 Aug 12;14(8):1764. doi: 10.3390/v14081764.